| Literature DB >> 29643755 |
Thamiris de A de Souza1,2, Marcio B P Lopes3, Aline de S Ramos2, José Luiz P Ferreira1,2, Jefferson Rocha de A Silva4, Margareth M C Queiroz3, Kátia G de Lima Araújo1, Ana Claudia F Amaral2.
Abstract
Species of the genus Alpinia are widely used by the population and have many described biological activities, including activity against insects. In this paper, we describe the bioactivity of the essential oil of two species of Alpinia genus, A. zerumbet and A. vittata, against Rhodnius nasutus, a vector of Chagas disease. The essential oils of these two species were obtained by hydrodistillation and analyzed by GC-MS. The main constituent of A. zerumbet essential oil (OLALPZER) was terpinen-4-ol, which represented 19.7% of the total components identified. In the essential oil of A. vittata (OLALPVIT) the monoterpene β-pinene (35.3%) was the main constituent. The essential oils and their main constituents were topically applied on R. nasutus fifth-instar nymphs. In the first 10 min of application, OLALPVIT and OLALPZER at 125 μg/mL provoked 73.3% and 83.3% of mortality, respectively. Terpinen-4-ol at 25 μg/mL and β-pinene at 44 μg/mL provoked 100% of mortality. The monitoring of resistant insects showed that both essential oils exhibited antifeedant activity. These results suggest the potential use of A. zerumbet and A. vittata essential oils and their major constituents to control R. nasutus population.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29643755 PMCID: PMC5832174 DOI: 10.1155/2018/2393858
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Alpinia zerumbet (Pers.) Burtt & Smith.
Figure 2Alpinia vittata W. Bull.
Chemical composition of the essential oils extracted of from fresh leaves of A. zerumbet (OLALPZER) and A. vittata (OLALPVIT) determined by GC-MS analyzes.
| Substances | Retention time | OLALPZER | OLALPVIT |
|---|---|---|---|
| (min) | Area (%) | Area (%) | |
|
| 12.6 | 3.7 | - |
|
| 12.9 | 1.7 | 10.1 |
| Camphene | 13.6 | 0.2 | - |
| Sabinene | 14.7 | 13.8 | 1.2 |
|
| 14.8 | 3.0 | 35.3 |
|
| 15.4 | 1.1 | - |
| Phellandrene | 16.1 | 0.3 | - |
|
| 16.6 | 4.0 | - |
|
| 16.9 | 4.8 | - |
| Limonene | 17.1 | 1.8 | 1.5 |
| 1,8-Cineol | 17.2 | 15.3 | - |
|
| - | 2.0 | - |
|
| 20 | 2.2 | - |
| Terpinen-4-ol | 23.2 | 19.7 | - |
|
| 29.0 | - | 2.1 |
| Copaene | 30 | - | 2.4 |
|
| 30.4 | - | 2.4 |
|
| 31.5 | 3.2 | 1.0 |
|
| 32.4 | - | 1.7 |
| Aromadendrene | 32.8 | - | 0.7 |
|
| 33.1 | - | 0.6 |
| Germacrene-D | 33.4 | - | 0.6 |
| epi-Bicyclosesquiphellandrene | 33.8 | - | 1.0 |
| epi-Cubebol | 33.9 | - | 5.0 |
| Calamenene | 34.7 | - | 2.0 |
| Cadina-1(2),4-diene | 35.0 | 0.8 | |
| Viridiflorol | 37.2 | 1.75 | |
| 1-epi-Cubenol | 37.8 | 1.43 | |
| 1,10-di-epi-Cubenol | 38.2 | 1.24 | |
| Caryophyllene oxide | 36.5 | 1.9 | - |
| Others | - | 21.2 | 27.2 |
Mass difference (mg) before and after feeding observed in R. nasutus treated with OLALPVIT and OLALPZER at 125 µg/µL under laboratory conditions.
| Groups (treatments) | 1st week | 2nd week | 3rd week | 4th week | 5th week | 6th week | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| IV |
| IV |
| IV |
| IV |
| IV |
| IV | |
| Pure control | 10.6 ± 4.5a | 0–114 | 7.8 ± 12.7a | 0–14 | 16.0 ± 26.7a | 0–104 | 28.9 ± 41.3a | 0–124 | 2.6 ± 5.8a | 0–24 | 12.0 ± 26.6a | 0–107 |
| DMSO control | 8.8 ± 2.9a | 0–54 | 6.4 ± 12.7a | 0–58 | 21.7 ± 41.1a | 0–140 | 14.5 ± 24.2a | 0–89 | 5.7 ± 9.2a | 0–29 | 3.6 ± 7.3a | 0–27 |
| OLALPVIT | 0.0 ± 0.0b | 0-0 | 0.0 ± 0.0a | 0-0 | 0.0 ± 0.0b | 0-0 | 0.0 ± 0.0b | 0-0 | 0.0 ± 0.0a | 0-0 | 0.0 ± 0.0a | 0-0 |
| OLALPZER | 0.0 ± 0.0b | 0-0 | 0.0 ± 0.0a | 0-0 | 0.0 ± 0.0b | 0-0 | 0.0 ± 0.0b | 0-0 | 0.0 ± 0.0a | 0-0 | 0.0 ± 0.0a | 0-0 |
χ, means; SD, standard deviation; IV, interval variation (range). Means followed by the same letter within each column are not significantly different according to Tukey's test (p < 0.05).
Development of R. nasutus (fifth-instar nymphs to adult) and longevity of adults treated with OLALPVIT and OLALPZER at 125 µg/µL.
| Groups | Development (days) | Longevity (days) | ||
|---|---|---|---|---|
|
| IV |
| IV | |
| Without treatment | 43.1 ± 17.7a | 16–79 | 31.5 ± 10.9a | 19–56 |
| DMSO | 39.9 ± 17.4a | 7–79 | 26.1 ± 13.7a | 12–70 |
| OLALPVIT | ND | ND | ND | ND |
| OLALPZER | 18.5 ± 23.3a | 2–35 | 22 ± 21.2a | 7–37 |
χ, means; SD, standard deviation; ND, not determined; IV, interval variation (range). Means followed by the same letter within each column are not significantly different according to Tukey's test (p < 0.05).
Mortality of R. nasutus fifth-instar nymphs treated with OLALPVIT, OLALPZER (125 µg/µL), and their main constituents, terpinen-4-ol (25 µg/µL), 1,8-cineol (19 µg/µL), α-pinene (12.5 µg/µL), and β-pinene (44 µg/µL).
| Groups | Mortality up to 10 min (%) | Mortality between 10 min and 72 h (%) |
|---|---|---|
| Without treatment | 0 | 0 |
| DMSO | 0 | 0 |
| OLALPVIT | 73.3 | 6.7 |
| OLALPZER | 83.3 | 3.3 |
| Terpinen-4-ol | 100 | 0 |
| 1,8-Cineol | 0 | 0 |
|
| 0 | 0 |
|
| 100 | 0 |
Figure 3Main substances present in the essential oils from leaves of A. zerumbet (terpinen-4-ol; 1,8-cineol) and A. vittata (α-pinene; β-pinene).